A detailed history of Barclays PLC transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Barclays PLC holds 101,953 shares of STXS stock, worth $246,726. This represents 0.0% of its overall portfolio holdings.

Number of Shares
101,953
Previous 101,953 -0.0%
Holding current value
$246,726
Previous $208,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$1.76 - $2.35 $146,805 - $196,018
83,412 Added 449.88%
101,953 $208,000
Q2 2024

Aug 14, 2024

BUY
$1.73 - $3.2 $32,075 - $59,331
18,541 New
18,541 $34,000
Q4 2023

Feb 15, 2024

SELL
$1.42 - $1.96 $26,252 - $36,236
-18,488 Reduced 83.82%
3,568 $6,000
Q3 2023

Nov 07, 2023

BUY
$1.42 - $1.84 $31,319 - $40,583
22,056 New
22,056 $35,000
Q2 2022

Aug 12, 2022

SELL
$1.75 - $3.71 $14,101 - $29,895
-8,058 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$3.11 - $6.63 $162,286 - $345,966
-52,182 Reduced 86.62%
8,058 $30,000
Q4 2021

Feb 14, 2022

BUY
$5.14 - $6.84 $205,384 - $273,312
39,958 Added 197.01%
60,240 $374,000
Q3 2021

Nov 09, 2021

BUY
$5.34 - $9.87 $74,776 - $138,209
14,003 Added 223.01%
20,282 $109,000
Q2 2021

Aug 13, 2021

SELL
$6.41 - $10.17 $196,645 - $311,995
-30,678 Reduced 83.01%
6,279 $61,000
Q1 2021

May 13, 2021

BUY
$4.43 - $7.95 $100,498 - $180,353
22,686 Added 158.97%
36,957 $249,000
Q4 2020

Feb 11, 2021

SELL
$3.11 - $5.3 $18,697 - $31,863
-6,012 Reduced 29.64%
14,271 $72,000
Q3 2020

Nov 12, 2020

SELL
$3.18 - $4.57 $19,083 - $27,424
-6,001 Reduced 22.83%
20,283 $73,000
Q2 2020

Aug 12, 2020

BUY
$2.71 - $5.47 $71,229 - $143,773
26,284 New
26,284 $118,000
Q1 2020

May 13, 2020

SELL
$1.77 - $5.4 $17 - $54
-10 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$2.99 - $5.29 $29 - $52
10 New
10 $0

Others Institutions Holding STXS

About Stereotaxis, Inc.


  • Ticker STXS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,790,096
  • Market Cap $181M
  • Description
  • Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...
More about STXS
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.